Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7607162 | 0.75 | HTR2A (0.39) | HTR2A | |
| SCHEMBL7606245 | 0.75 | HTR2A (0.39) | HTR2A | |
| Hydrochloric Acid SCHEMBL8677593 | 0.74 | HTR2A (0.38) | HTR2A | |
| Hydrochloric Acid SCHEMBL5353652 | 0.74 | HTR2A (0.38) | HTR2A | |
| Hydrochloric Acid SCHEMBL5352121 | 0.74 | HTR2A (0.38) | HTR2A | |
| SCHEMBL6558691 | 0.70 | HTR2A (0.33) | HTR2A | |
| SCHEMBL7609039 | 0.70 | HTR2A (0.33) | HTR2A | |
| SCHEMBL6557932 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL6559590 | 0.70 | — | — | |
| SCHEMBL7603806 | 0.70 | HTR2A (0.33) | HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7700694-B2 | Catalyst composition and method for hydrogenating a polymer having a conjugated diene | TSRC CORPORATION (TW) | 2010-04-20 | — | — | US | claimed |
| US-7612148-B2 | Hydrogenation catalyst composition and method for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2009-11-03 | — | — | US | claimed |
| US-20080146733-A1 | Hydrogenation catalyst composition and method for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2008-06-19 | — | — | US | claimed |
| US-20070254802-A1 | Catalyst composition and method for hydrogenating a polymer having a conjugated diene | TSRC CORPORATION (TW) | 2007-11-01 | — | — | US | claimed |
| EP-3327041-B1 | PROCESS AND CATALYST COMPOSITION FOR PRODUCING SELECTIVELY HYDROGENATED CONJUGATED DIENE POLYMER | TSRC CORP (TW) | 2024-04-10 | — | — | EP | disclosed |
| US-11208505-B2 | Process and catalyst composition for producing selectively hydrogenated conjugated diene polymer | TSRC CORPORATION (TW) | 2021-12-28 | — | — | US | disclosed |
| US-20200223952-A1 | PROCESS AND CATALYST COMPOSITION FOR PRODUCING SELECTIVELY HYDROGENATED CONJUGATED DIENE POLYMER | TSRC CORPORATION (TW) | 2020-07-16 | — | — | US | disclosed |
| US-10590209-B2 | Process and catalyst composition for producing selectively hydrogenated conjugated diene polymer | TSRC CORPORATION (TW) | 2020-03-17 | — | — | US | disclosed |
| US-20180148520-A1 | PROCESS AND CATALYST COMPOSITION FOR PRODUCING SELECTIVELY HYDROGENATED CONJUGATED DIENE POLYMER | TSRC CORP (TW) | 2018-05-31 | — | — | US | disclosed |
| EP-3327041-A1 | PROCESS AND CATALYST COMPOSITION FOR PRODUCING SELECTIVELY HYDROGENATED CONJUGATED DIENE POLYMER | TSRC Corporation (TW) | 2018-05-30 | — | — | EP | disclosed |
| US-7700694-B2 | Catalyst composition and method for hydrogenating a polymer having a conjugated diene | TSRC CORPORATION (TW) | 2010-04-20 | — | — | US | disclosed |
| US-20070254802-A1 | Catalyst composition and method for hydrogenating a polymer having a conjugated diene | TSRC CORPORATION (TW) | 2007-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10590209-B2 | Process and catalyst composition for producing selectively hydrogenated conjugated diene polymer | PARG, CAD, PICALM | HTR2A 4185/4885 |
| US-11208505-B2 | Process and catalyst composition for producing selectively hydrogenated conjugated diene polymer | PARG, CAD, PICALM | HTR2A 4185/4885 |
| US-20180148520-A1 | PROCESS AND CATALYST COMPOSITION FOR PRODUCING SELECTIVELY HYDROGENATED CONJUGATED DIENE POLYMER | PARG, CAD, PICALM | HTR2A 4185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.